AHRENS BRENTON KARL sold 54.7% of their position (45K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market sale worth $93.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/15/2022ACC: 0000899243-22-031172
Director
Since May 2019
-45K
Net shares
Net seller
$93.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
45K disposed
Non-Derivative Transactions3
Ordinary Shares
Indirect
Shares
−15K
Price / share
$2.14
Trade value
$32.12K
% of position
18.2%
9/13/2022
82.25K→67.25K
Ordinary Shares
Indirect
Shares
−15K
Price / share
$2.10
Trade value
$31.46K
% of position
22.3%
9/14/2022
67.25K→52.25K
Ordinary Shares
Indirect
Shares
−15K
Price / share
$2.02
Trade value
$30.27K
% of position
28.7%
9/15/2022
52.25K→37.25K
Total
Net shares
−45K
Net value
-$93.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Indirect | 9/13/2022 | S · Sale | −15K | $2.14 | $32.12K | 18.2% | 82.25K | 67.25K |
| Ordinary Shares Indirect | 9/14/2022 | S · Sale | −15K | $2.10 | $31.46K | 22.3% | 67.25K | 52.25K |
| Ordinary Shares Indirect | 9/15/2022 | S · Sale | −15K | $2.02 | $30.27K | 28.7% | 52.25K | 37.25K |
| Total | −45K | -$93.85K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
DirectShares owned410.00
Total
410.00 direct410.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 410.00 | Direct |
| Total | 410.00 | 410.00 direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported